Race study for prostate cancer drug withdrawn before start
NCT ID NCT06527690
Summary
This study aimed to see if race affects how well a standard prostate cancer drug combination works for men with specific genetic changes in their tumors. It planned to enroll Black, Hispanic, White, and Native American men with advanced prostate cancer that had stopped responding to hormone therapy. The trial was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.